featured
MY APPROACH to Paxlovid (nirmatrelvir/ritonavir) Prescribing: a Guide for Primary Care Providers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Paxlovid [product monograph]. Canada: Pfizer. Authorized January 22, 2022.
- COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Accessed 12 May, 2022.
- Ontario COVID-19 Drugs and Biologics Clinical Practice Guidelines Working Group, University of Waterloo School of Pharmacy. Nirmatrelvir/Ritonavir (Paxlovid): What prescribers and pharmacists need to know. Ontario COVID-19 Science Advisory Table. 2022;3(58).